पाज़ोपैनिब और रैनिटिडीन का इंटरैक्शन

Concomitant Use With Gastric Acid-Reducing Agents : Avoid concomitant use of VOTRIENT with gastric acid-reducing agents.

Avoid concomitant use of VOTRIENT with gastric acid-reducing agents.

If concomitant administration with a gastric acid-reducing agent cannot be avoided, consider short-acting antacids in place of PPIs and H2-receptor antagonists.

Consider short-acting antacids in place of proton pump inhibitors (PPIs) and H2-receptor antagonists.

Concomitant Use With Gastric Acid-Reducing Agents Concomitant use of VOTRIENT with esomeprazole, a PPI, decreased the exposure of pazopanib.